The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...
Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback